当前位置: 首页 >> 检索结果
361. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies.
作者: Charalambos V Vlachopoulos.;Dimitrios G Terentes-Printzios.;Nikolaos K Ioakeimidis.;Konstantinos A Aznaouridis.;Christodoulos I Stefanadis.
来源: Circ Cardiovasc Qual Outcomes. 2013年6卷1期99-109页
Erectile dysfunction (ED) carries an independent risk for cardiovascular (CV) events. We conducted a meta-analysis of all longitudinal studies for determining the ability of ED to predict risk of clinical events and to dissect factors influencing this ability.
362. Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.
作者: Meng Lee.;Jeffrey L Saver.;Keun-Sik Hong.;Hsiu-Chuan Wu.;Bruce Ovbiagele.
来源: Circ Heart Fail. 2013年6卷2期287-92页
The risk-benefit profile of warfarin versus aspirin for patients with heart failure in normal sinus rhythm has not been definitively established. Our objective was to evaluate the overall comparative effects of warfarin and aspirin in patients with heart failure and normal sinus rhythm.
363. Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies.
作者: Bing Yu.;Maja Barbalic.;Ariel Brautbar.;Vijay Nambi.;Ron C Hoogeveen.;Weihong Tang.;Thomas H Mosley.;Jerome I Rotter.;Christopher R deFilippi.;Christopher J O'Donnell.;Sekar Kathiresan.;Ken Rice.;Susan R Heckbert.;Christie M Ballantyne.;Bruce M Psaty.;Eric Boerwinkle.; .
来源: Circ Cardiovasc Genet. 2013年6卷1期82-8页
High levels of cardiac troponin T, measured by a highly sensitive assay (hs-cTnT), are strongly associated with incident coronary heart disease and heart failure. To date, no large-scale genome-wide association study of hs-cTnT has been reported. We sought to identify novel genetic variants that are associated with hs-cTnT levels.
364. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies.
作者: Lu Wang.;Yiqing Song.;Joann E Manson.;Stefan Pilz.;Winfried März.;Karl Michaëlsson.;Annamari Lundqvist.;Simerjot K Jassal.;Elizabeth Barrett-Connor.;Cuilin Zhang.;Charles B Eaton.;Heidi T May.;Jeffrey L Anderson.;Howard D Sesso.
来源: Circ Cardiovasc Qual Outcomes. 2012年5卷6期819-29页
Vitamin D status has been linked to the risk of cardiovascular disease (CVD). However, the optimal 25-hydroxy-vitamin D (25[OH]-vitamin D) levels for potential cardiovascular health benefits remain unclear.
365. Why does primary angioplasty not work in registries? Quantifying the susceptibility of real-world comparative effectiveness data to allocation bias.
作者: Sayan Sen.;Justin E Davies.;Iqbal S Malik.;Rodney A Foale.;Ghada W Mikhail.;Nearchos Hadjiloizou.;Alun Hughes.;Jamil Mayet.;Darrel P Francis.
来源: Circ Cardiovasc Qual Outcomes. 2012年5卷6期759-66页
Meta-analysis of registries (comparative effectiveness research) shows that primary angioplasty and fibrinolysis have equivalent real-world survival. Yet, randomized, controlled trials consistently find primary angioplasty superior. Can unequal allocation of higher-risk patients in registries have masked primary angioplasty benefit?
366. Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses.
作者: Kenji Sakata.;Katsuhisa Waseda.;Teruyoshi Kume.;Hiromasa Otake.;Daisaku Nakatani.;Paul G Yock.;Peter J Fitzgerald.;Yasuhiro Honda.
来源: Circ Cardiovasc Interv. 2012年5卷6期763-71页
Exaggerated neointimal hyperplasia is considered as the primary mechanism for increased restenosis in patients with diabetes mellitus (DM) treated with bare-metal stent. However, the vessel response in DM and non-DM treated with different drug-eluting stents (DES) has not been systematically evaluated.
367. Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis.
作者: Sradha Kotwal.;Min Jun.;David Sullivan.;Vlado Perkovic.;Bruce Neal.
来源: Circ Cardiovasc Qual Outcomes. 2012年5卷6期808-18页
Early trials evaluating the effect of omega 3 fatty acids (ω-3 FA) reported benefits for mortality and cardiovascular events but recent larger studies trials have variable findings. We assessed the effects of ω-3 FA on cardiovascular and other important clinical outcomes.
368. Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases: a meta-analysis.
Secondhand smoke causes cardiovascular and respiratory disease. Smoke-free legislation is associated with a lower risk of hospitalization and death from these diseases.
369. Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.
作者: Francesco Dentali.;Nicoletta Riva.;Mark Crowther.;Alexander G G Turpie.;Gregory Y H Lip.;Walter Ageno.
来源: Circulation. 2012年126卷20期2381-91页
Novel oral anticoagulants (NOACs) have been proposed as alternatives to vitamin K antagonists for the prevention of stroke and systemic embolism in patients with atrial fibrillation. Individually, NOACs were at least noninferior to vitamin K antagonists, but a clear superiority in overall and vascular mortality was not consistently proven.
370. Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis.
作者: Matthew W Parker.;Aline Iskandar.;Brendan Limone.;Andrew Perugini.;Hyejin Kim.;Charles Jones.;Brian Calamari.;Craig I Coleman.;Gary V Heller.
来源: Circ Cardiovasc Imaging. 2012年5卷6期700-7页
Positron emission tomography (PET) myocardial perfusion imaging (MPI) offers technical benefits compared with single photon emission computed tomography (SPECT) MPI, but there has been no systematic comparison of their diagnostic accuracy for coronary artery disease. We performed a bivariate meta-analysis of the published literature to compare the sensitivity and specificity of PET versus SPECT stress MPI for ≥50% stenosis of any epicardial coronary artery in patients with known or suspected coronary artery disease.
371. Association of mild to moderate chronic kidney disease with venous thromboembolism: pooled analysis of five prospective general population cohorts.
作者: Bakhtawar K Mahmoodi.;Ron T Gansevoort.;Inger Anne Næss.;Pamela L Lutsey.;Sigrid K Brækkan.;Nic J G M Veeger.;Ellen E Brodin.;Karina Meijer.;Yingying Sang.;Kunihiro Matsushita.;Stein I Hallan.;Jens Hammerstrøm.;Suzanne C Cannegieter.;Brad C Astor.;Josef Coresh.;Aaron R Folsom.;John-Bjarne Hansen.;Mary Cushman.
来源: Circulation. 2012年126卷16期1964-71页
Recent findings suggest that chronic kidney disease (CKD) may be associated with an increased risk of venous thromboembolism (VTE). Given the high prevalence of mild-to-moderate CKD in the general population, in depth analysis of this association is warranted.
372. Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates.
作者: Deborah Siegal.;Jovana Yudin.;Scott Kaatz.;James D Douketis.;Wendy Lim.;Alex C Spyropoulos.
来源: Circulation. 2012年126卷13期1630-9页
Periprocedural bridging with unfractionated heparin or low-molecular-weight heparin aims to reduce the risk of thromboembolic events in patients receiving long-term vitamin K antagonists. Optimal periprocedural anticoagulation has not been established.
373. Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation.
Oral anticoagulants such as apixaban, dabigatran, and rivaroxaban are alternatives to warfarin for preventing events in patients with atrial fibrillation. Direct comparative studies between agents are unavailable. Our objective was to conduct an adjusted indirect comparison meta-analysis between new oral agents in atrial fibrillation.
374. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.
作者: Seema Pursnani.;Frederick Korley.;Ravindra Gopaul.;Pushkar Kanade.;Newry Chandra.;Richard E Shaw.;Sripal Bangalore.
来源: Circ Cardiovasc Interv. 2012年5卷4期476-90页
The role of percutaneous coronary intervention (PCI) in the management of stable coronary artery disease remains controversial. Given advancements in medical therapies and stent technology over the last decade, we sought to evaluate whether PCI, when added to medical therapy, improves outcomes when compared with medical therapy alone.
375. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials.
作者: Salvatore Cassese.;Robert A Byrne.;Ilka Ott.;Gjin Ndrepepa.;Mateja Nerad.;Adnan Kastrati.;Massimiliano Fusaro.
来源: Circ Cardiovasc Interv. 2012年5卷4期582-9页
In disease of the femoropopliteal artery, paclitaxel-coated balloon (PCB) therapy improved angiographic outcomes as compared with uncoated balloon (UCB) angioplasty. Nevertheless, it remains uncertain whether PCB may reduce the need for reintervention.
376. Association of obstructive sleep apnea with risk of serious cardiovascular events: a systematic review and meta-analysis.
作者: Yoon K Loke.;J William L Brown.;Chun Shing Kwok.;Alagaratnam Niruban.;Phyo K Myint.
来源: Circ Cardiovasc Qual Outcomes. 2012年5卷5期720-8页
The relationship between obstructive sleep apnea (OSA) and cardiovascular events remains unclear. We conducted a systematic review to determine the incident risk of cardiovascular events among patients with OSA.
377. Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis.
作者: Arend F L Schinkel.;Pieter A Vriesendorp.;Eric J G Sijbrands.;Luc J L M Jordaens.;Folkert J ten Cate.;Michelle Michels.
来源: Circ Heart Fail. 2012年5卷5期552-9页
Previous observational studies demonstrated that patients with hypertrophic cardiomyopathy at risk for sudden cardiac death (SCD) may benefit from implantable cardioverter defibrillator (ICD) therapy. A complete overview of outcome and complications after ICD therapy is currently not available. This study pools data from published studies on outcome and complications after ICD therapy in patients with hypertrophic cardiomyopathy.
378. Coronary artery calcium and primary prevention risk assessment: what is the evidence? An updated meta-analysis on patient and physician behavior.
作者: Seamus P Whelton.;Khurram Nasir.;Michael J Blaha.;Heidi Gransar.;Thomas S Metkus.;Josef Coresh.;Daniel S Berman.;Roger S Blumenthal.
来源: Circ Cardiovasc Qual Outcomes. 2012年5卷4期601-7页
While the Framingham Risk Score provides a reasonable estimation of risk in certain subgroups, the majority of MIs occur in individuals classified as low or moderate risk. Coronary Artery Calcium (CAC) testing provides an individualized measure of atherosclerotic burden that integrates an individual’s cumulative lifetime risk factor exposure that cannot be obtained from serum markers.
379. Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis.
作者: Elizabeth Mostofsky.;Megan S Rice.;Emily B Levitan.;Murray A Mittleman.
来源: Circ Heart Fail. 2012年5卷4期401-5页
There have been discrepant findings on the association between coffee consumption and risk of incident heart failure.
380. Systematic review and cost-benefit analysis of radial artery access for coronary angiography and intervention.
作者: Matthew D Mitchell.;Jaekyoung A Hong.;Bruce Y Lee.;Craig A Umscheid.;Sarah M Bartsch.;Creighton W Don.
来源: Circ Cardiovasc Qual Outcomes. 2012年5卷4期454-62页
Radial artery access for coronary angiography and interventions has been promoted for reducing hemostasis time and vascular complications compared with femoral access, yet it can take longer to perform and is not always successful, leading to concerns about its cost. We report a cost-benefit analysis of radial catheterization based on results from a systematic review of published randomized controlled trials.
|